| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
4e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.25 |
1e-05 |
| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
1e-05 |